VRPX News and Press, Virpax Pharmaceuticals Inc. From 06/02/25

Hypha Labs Inc Com (New) (FUNI) is expected to report for Q2 2025 XTL Biopharmaceuticals Ltd. (XTLB) is expected to report for quarter end 2025-03-31 Onconetix Inc. (ONCO) is expected to report for quarter end 2025-03-31 Baosheng Media Group Holdings Limited (BAOS) is expected to repo...

Lufax Holding Ltd American Depositary Shares each representing two (2) (LU) is expected to report for Q1 2025 RiceBran Technologies (RIBT) is expected to report for quarter end 2025-03-31 Novo Integrated Sciences Inc. (NVOS) is expected to report for quarter end 2025-02-28 Voestalpine...

Global Ship Lease Inc New Class A (GSL) is expected to report $2.27 for Q1 2025 Biolase Inc. (BIOLQ) is expected to report for quarter end 2025-03-31 ViewBix Inc (VBIXD) is expected to report for Q1 2025 8x8 Inc (EGHT) is expected to report $0.01 for Q4 2025 Gaucho Group Hol (VINO...

Redwire Corporation (RDW) is expected to report $-0.2 for Q1 2025 Organigram Global Inc. (OGI) is expected to report $-0.03 for Q2 2025 Inter & Co. Inc. (INTR) is expected to report $0.12 for Q1 2025 Pervasip Corp (PVSP) is expected to report for quarter end 2025-02-28 Maui La...

2025-03-21 09:01:56 ET Virpax Pharmaceuticals, Inc. (VRPX) announced stock split at a ratio of 1-for-25 on 2025-03-21 ... Full story available on KlickAnalytics.com

2025-03-19 08:12:14 ET More on Virpax Pharmaceuticals Seeking Alpha’s Quant Rating on Virpax Pharmaceuticals Historical earnings data for Virpax Pharmaceuticals Read the full article on Seeking Alpha For further details see: Virpax Pharmaceuticals ...

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”) a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, today ann...

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”) , a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, today...

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”) , a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, is lo...

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”) , a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and anti-viral barrier indications, is pl...